Literature DB >> 31611209

IFCC-HbA1c May Be More Useful than NGSP-HbA1c in the Comparison between HbA1c Values in Variant Hemoglobin with a Mutation on α Chain and β Chain.

Masafumi Koga1, Shinya Inada2, Kei Yoshino3, Ayako Miyazaki4.   

Abstract

HbA1c values in variant hemoglobin with a mutation on α chain and β chain are assumed to be different because the α chain and β chain of the globin gene have two and one gene(s), respectively. We examined whether the differentiation between HbA1c values in variant hemoglobin with a mutation on α chain (C1α) and β chain (C1β) is possible. Three patients with C1α and 9 patients with C1β were included. HbA1c was measured by standard mode high-performance liquid chromatography (HPLC) (HPLC-HbA1c) and immunoassay (IA: IA-HbA1c). Glycated albumin (GA) was determined, and each ratio was compared. HbA1c is expressed in National Glycohemoglobin Standardization Program (NGSP) units (A1C) and International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) units (iA1c). Both the HPLC-A1C/IA-A1C ratio and the HPLC-iA1c/IA-iA1c ratio in C1α were significantly lower than those in C1β. Although there were no significant differences between the GA/HPLC-A1C ratios in both groups, the GA/HPLC-iA1c ratio in C1α was significantly higher than those in C1β. If the cutoff values for the HPLC/IA-iA1c ratio and GA/HPLC-iA1c ratio were set at 65% and 5.3, respectively, both sensitivity and specificity were 100%. Differentiation between C1α and C1β might be possible by using the HPLC-iA1c/IA-iA1c ratio or GA/HPLC-iA1c ratio.
© 2019 by the Association of Clinical Scientists, Inc.

Entities:  

Keywords:  Globin gene; Glycated albumin; HbA1c; High-performance liquid chromatography; Variant hemoglobin

Mesh:

Substances:

Year:  2019        PMID: 31611209

Source DB:  PubMed          Journal:  Ann Clin Lab Sci        ISSN: 0091-7370            Impact factor:   1.256


  1 in total

1.  Clinical characteristics on manifestation and gene mutation of a transient neonatal cyanosis: A case report.

Authors:  Jing Yuan; Xue-Ping Zhu
Journal:  World J Clin Cases       Date:  2020-01-06       Impact factor: 1.337

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.